Key Figures (US\$ million)Second quarter ended 31.320202019Revenue351.7348.6Of Which:Integrated Solutions & Services237.9226.8Applied Product Technologies113.8121.8Cost of Products Sold240.5253.0Gross Profit111.295.6R&D Expenses3.24.0Profit/(Loss) before Income Taxes7.9(3.0)Net Income attributable to Evoqua7.81.4Six months ended 31.320202019Revenue697.8671.6Cost of Products Sold480.8487.3Gross Profit216.9184.3R&D Expenses6.98.1Profit/(Loss) before Income Taxes64.0(23.8)Net Income/(Loss) attributable to Evoqua61.0(15.3)Source: Evoqua Q2 2020 results.

COMMENTWater treatment specialist Evoqua has posted second quarter fiscal 2020 revenues of US\$351.7 million, an increase of 0.9% on the year prior, while net profit soared to US\$7.8 million.Revenues were up 3.4% organically, which offset the impact of divestments and currency translation.Sales in the company\'s Integrated Solutions & Services segment were up 4.9% on the year earlier to US\$237.9 million, on the back of strong demand in the microelectronics end market.In contrast, sales in the Applied Product Technologies sector were down 6.4% on the year earlier at US\$113.8 million which reflected the divestment of the Memcor product line that masked a 1.3% growth on an organic basis.The five-fold surge in net income compared to the fiscal 2019 comparator reflected a US\$9.0 million pre-tax gain from the Memcor sale."The challenges posed by Covid-19 have impacted every facet of how we conduct our daily lives and how businesses adapt to significant demand shifts and maintain supply chain integrity," Ron Keating, Evoqua\'s CEO, said. "Evoqua personnel servicing the front-line health care and other essential service professionals are responding by conducting their daily activities with a sense of duty and courage, and we extend them our sincere appreciation. I am very proud of all of our employees for stepping up and being responsive, particularly in this dynamic environment."[www.evoqua.com](http://www.evoqua.com){#interrefs10}
